Vanguard Global Advisers’s Lisata Therapeutics LSTA Stock Holding History
Bought
Maintained
Sold
Other funds holding LSTA
SFCM
Vanguard Global Advisers's LSTA Position: Q3 2026 in Review
Vanguard Global Advisers held its Lisata Therapeutics (LSTA) position steady in Q3 2026 at 1,033 shares worth $1.49K. The position accounts for ﹤0.01% of the portfolio, ranked #3686.
Vanguard Global Advisers first reported a position in LSTA in Q1 2026 and has held it in 3 quarters since. The position peaked at $5.18K in Q1 2026. 38 funds tracked by Wall St. Rank hold LSTA as of Q3 2026.
- Vanguard Global Advisers held 1,033 shares of Lisata Therapeutics worth $1.49K as of Q3 2026.
- Vanguard Global Advisers left its Lisata Therapeutics share count unchanged in Q3 2026.
- Lisata Therapeutics made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #3686 holding.
- Vanguard Global Advisers first reported a position in Lisata Therapeutics in Q1 2026 and has held it in 3 quarters since.
- Vanguard Global Advisers's Lisata Therapeutics position peaked at $5.18K in Q1 2026.
- 38 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q3 2026.
Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.